Clinical Intervention Psychosis and Addiction

Early Phase 1

• Conditions: Psychosis; Substance Abuse

• Registration Number: NCT01411566
• Lead Sponsor: University of Cologne

Brief Summary

The purpose of this study is to evaluate an integrative therapeutic concept for schizophrenic patients with comorbid substance use disorder.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01
• Status Verified: 2011-02
• Study First Submitted: 2011-03-02
• Study First Submitted QC: 2011-08-05
• Last Update Submitted: 2011-08-05
• Study First Posted: 2011-08-08
• Last Update Posted: 2011-08-08
• Primary Completion: 2011-11
• Study Completion: 2011-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

• Schizophrenia
• Addiction
• Written statement of agreement
• Majority

Exclusion Criteria

• Acute psychosis
• Further neuropsychiatric disorder

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Substance use	6 months
Change in drug use motivation	1 year

Trial Locations

Locations (1)

LVR Clinic Cologne - Academic Clinic of the University of Cologne; 🇩🇪 Cologne, Germany